ORCHESTRA BIOMED HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.95 USD | +1.43% |
|
-10.81% | -45.78% |
Evolution of the average Target Price on Orchestra BioMed Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
9e9e563014470824d6786dcfa9d.GjUBi7jt_wNrPF_TovdIoRkOWL5tlxZ-BhzcgkHA9iU.I2R25vy0j3VSDQWJm40XllpMFNkF8yMKdyS0xhWyl110f1a67MCsNjtlFg~db3c628cafcc299d65b9c0c42c63221c
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.88
USD
Average target price
16.33
USD
Spread / Average Target
+234.70%
High Price Target
20
USD
Spread / Highest target
+309.84%
Low Price Target
14
USD
Spread / Lowest Target
+186.89%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Orchestra BioMed Holdings, Inc.
| Jefferies & Co. | |
| Piper Sandler | |
| Chardan Research |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- OBIO Stock
- Consensus Orchestra BioMed Holdings, Inc.